Cargando…

Parathyroid Hormone versus Bisphosphonate Treatment on Bone Mineral Density in Osteoporosis Therapy: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Bisphosphonates and parathyroid hormone (PTH) represent the antiresorptive and anabolic classes of drugs for osteoporosis treatment. Bone mineral density (BMD) is an essential parameter for the evaluation of anti-osteoporotic drugs. The aim of this study was to evaluate the effects of PT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Longxiang, Xie, Xuetao, Su, Yan, Luo, Congfeng, Zhang, Changqing, Zeng, Bingfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192168/ https://www.ncbi.nlm.nih.gov/pubmed/22022584 http://dx.doi.org/10.1371/journal.pone.0026267

Ejemplares similares

The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
por: Migliaccio, Silvia, et al.
Publicado: (2007)

Comparison of Operative and Non-Operative Treatment of Acute Undisplaced or Minimally-Displaced Scaphoid Fractures: A Meta-Analysis of Randomized Controlled Trials
por: Shen, Longxiang, et al.
Publicado: (2015)

Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates
por: Heckman, George A, et al.
Publicado: (2002)

Correlation of vitamin D, bone mineral density and parathyroid hormone levels in adults with low bone density
por: Kota, Sunil, et al.
Publicado: (2013)

Comparison between teriparatide and bisphosphonates for improving bone mineral density in postmenopausal osteoporosis patients: A meta-analysis
por: Fan, Guiyong, et al.
Publicado: (2020)

Relationship between Vitamin D, Parathyroid Hormone, and Bone Mineral Density in Elderly Koreans
por: Kim, Guilsun, et al.
Publicado: (2012)

The Efficacy of Parathyroid Hormone Analogues in Combination With Bisphosphonates for the Treatment of Osteoporosis: A Meta-Analysis of Randomized Controlled Trials
por: Li, Wan, et al.
Publicado: (2015)

Bisphosphonates and parathyroid hormone analogs for improving bone quality in spinal fusion: State of evidence
por: Atesok, Kivanc, et al.
Publicado: (2020)

Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials
por: Lou, Shenghan, et al.
Publicado: (2018)

The association of bone mineral density and parathyroid hormone with serum magnesium in adult patients with sickle-cell anaemia
por: Elshal, Mohamed F., et al.
Publicado: (2012)

Strontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment
por: Brun, Lucas R, et al.
Publicado: (2014)

Effects of Bisphosphonate Therapy on Bone Mineral Density in Boys with Duchenne Muscular Dystrophy
por: Ronsley, Rebecca, et al.
Publicado: (2020)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

Single and Combined use of Human Parathyroid Hormone (PTH) (1-34) on Areal Bone Mineral Density (aBMD) in Postmenopausal Women with Osteoporosis: Evidence Based on 9 RCTs
por: Song, Jiefu, et al.
Publicado: (2014)

Influence of Vitamin K on Bone Mineral Density and Osteoporosis
por: Elshaikh, Abeer O, et al.
Publicado: (2020)

Increase in the Serum Parathyroid Hormone Level During a Bisphosphonate Drug Holiday
por: Song, Yoon Kyung, et al.
Publicado: (2014)

Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
por: Walls, J., et al.
Publicado: (1994)

Effects of a 'Drug Holiday' on Bone Mineral Density and Bone Turnover Marker During Bisphosphonate Therapy
por: Kong, Sung Yeol, et al.
Publicado: (2013)

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
por: Kamimura, M., et al.
Publicado: (2016)

Influence of vitamin D levels on bone mineral density and osteoporosis
por: Sadat-Ali, Mir, et al.
Publicado: (2011)

Associated Factors of Bone Mineral Density and Osteoporosis in Elderly Males
por: Heidari, Behzad, et al.
Publicado: (2016)

Change in Bone Mineral Density in Stroke Patients with Osteoporosis or Osteopenia
por: Lee, Do-Hee, et al.
Publicado: (2022)

Immunolocalization of Enzymes/Membrane Transporters Related to Bone Mineralization in the Metaphyses of the Long Bones of Parathyroid-Hormone-Administered Mice
por: Mae, Takahito, et al.
Publicado: (2023)

Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing
por: Kuroshima, S., et al.
Publicado: (2013)

Bisphosphonates, vitamin D, parathyroid hormone, and osteonecrosis of the jaw. Could there be a missing link?
por: Leizaola-Cardesa, Ignacio-Osoitz, et al.
Publicado: (2016)

Comparison of the efficacy of three once-weekly bisphosphonates on bone mineral density gains in Korean women
por: Lee, Ji Hyun, et al.
Publicado: (2013)

Comparative effects of denosumab or bisphosphonate treatment on bone mineral density and calcium metabolism in postmenopausal women
por: Augoulea, A., et al.
Publicado: (2017)

Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis
por: Arends, Suzanne, et al.
Publicado: (2020)

The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis
por: Deane, Andrew, et al.
Publicado: (2007)

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
por: Kaneko, Tetsuya, et al.
Publicado: (2019)

Bone Mineral Density, Parathyroid Hormone, and Vitamin D After Gastric Bypass Surgery: a 10-Year Longitudinal Follow-Up
por: Raoof, Mustafa, et al.
Publicado: (2020)

Bone mineral density and gene-environment interactions in the search for osteoporosis genes.
por: Sambrook, P, et al.
Publicado: (1999)

Comprehensive Analysis of the Genetic and Epigenetic Mechanisms of Osteoporosis and Bone Mineral Density
por: Dong, Hui, et al.
Publicado: (2020)

Bone mineral density and osteoporosis risk in young adults with atopic dermatitis
por: Kim, Sooyoung, et al.
Publicado: (2021)

Bone Mineral Density Screening Interval and Transition to Osteoporosis in Asian Women
por: Park, Hyunju, et al.
Publicado: (2022)

Factors affecting bone mineral density in children and adolescents with secondary osteoporosis
por: Jang, Min Jeong, et al.
Publicado: (2023)

Bisphosphonate's and Intermittent Parathyroid Hormone's Effect on Human Spinal Fusion: A Systematic Review of the Literature
por: Stone, Michael A., et al.
Publicado: (2017)

Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis
por: Kan, Shun-Li, et al.
Publicado: (2016)

Difference in Bone Mineral Density Change at the Lateral Femoral Cortices according to Administration of Different Bisphosphonate Agents
por: Kim, Sungjun, et al.
Publicado: (2016)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jkcbe438cqt89rh2ibrjji6dki